In the current study, TGF-β1, the Th3 cytokine, showed lower value inpatients with major depression than healthy controls, and plasma TGF-β1 levelswere significantly increased after 8-week treatment with sertraline aspreviously reported (Lee and Kim [30], Myint et al.[28]). This evidence concerns the gene TGFB1 and major depressive disorder.